ADX-3

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameADX-3
Drug Alias NameADX-3 program (Addex)ADX-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSchizophreniaAnxiety DisordersTobacco Use Disorder +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAddex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAddex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsSchizophreniaAnxiety DisordersTobacco Use Disorder +[4] 

Other Information

ATC CodeN/A
Related LinksN/A